Compositions and methods of using nintedanib for improving glaucoma surgery success
AssigneeCloudbreak Therapeutics, LLC
InventorsJinsong Ni, Rong Yang
Life of this patent
Estimating the term…
Abstract
Compositions and methods of using nintedanib for improving the success rate of glaucoma filtration surgery are disclosed herein. Nintedanib can be used alone or in combination with an anti-metabolite drug in a topical or implant eye formulation.
Claims27
A method for improving success rate of glaucoma surgery, comprising administering to an eye of a subject in need thereof a therapeutically effective amount of axitinib, pazopanib, or regorafenib.
A method of adjunctive treatment associated with glaucoma surgery in a subject, the method comprising administering to a subject in need thereof an effective amount of a composition comprising axitinib, pazopanib, or regorafenib.
A method for improving success rate of implanting a stent in glaucoma surgery, comprising administering to an eye of a subject in need thereof a therapeutically effective amount of axitinib, pazopanib, or regorafenib.
Dependencies are inferred from the claim text.